Utrecht Holdings participated in a round that will support the cancer immunotherapy spinout as it looks to advance a leukaemia candidate into clinical testing.

Baxalta's corporate venturing vehicle co-led a round that will support the cancer immunotherapy developer as it looks to advance a leukaemia candidate into clinical testing.

The Harvard spinout has raised a second funding round that included existing shareholder Cedars-Sinai, boosting its total equity funding to $40m.

The Cambridge spinout previously raised a $2.5m series A round backed by the university and up to $3.4m in a 2014 funding round backed by Parkwalk Advisors.

The Freiburg spinout has secured an undisclosed amount from Aesculap that is said to be one of the largest corporate venturing investments in a German spinout to date.

Blue Cross and Blue Shield Association led the oncology management company's funding round through its corporate venturing affiliate.

The Russia-based conglomerate is partnering Tsinghua University's business arm and putting up 30% of the capital for a fund that will be sized at up to $100m.

The Russia-based conglomerate is partnering Tsinghua University's business arm and putting up 30% of the capital for a fund that will be sized at up to $100m.

Biocodex led the round, which will fund the start of clinical studies for Maat's microbiome-based dysbiosis treatment this summer.

Alibaba's health IT subsidiary will pay $34.5m for a 25% stake in Wanilyun Medical Information Technology, a medical imaging spinout of Wandong Medical.